Thane police have clarified a viral video showing a disoriented man. The man was not under the influence of a 'zombie drug'. He had taken a...

The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...

The government is looking to control the sale of Pregabalin. This common medicine is being misused. The government wants to make sure it is...

Persistent foot pain or burning can signal unstable blood sugar, often linked to diabetes or vitamin B12 deficiency. Diabetic neuropathy, c...

The market hates uncertainty. Post the big reforms (GST and banking), the markets should have ideally been in upbeat mode this festive seas...

The All India Organisation of Chemists and Druggists (AIOCD) has appealed to Amit Shah. They want immediate action against e-pharmacies and...

The domestic brokerage on Monday reported a consolidated net profit at Rs 423 crore in Q2FY25, which was up 39% from Rs 304 crore reported ...

The Drugs Controller General of India (DCGI) is considering banning over-the-counter (OTC) sales of pain relievers Tapentadol and Pregabali...

Uniparts India will be listed at bourses on Monday. Its Rs 835.6 crore IPO was open was open between November 30 and December 2, sold in th...

The government has hiked the windfall profit tax on the export of diesel to Rs 13.5 per litre and on jet fuel exports to Rs 9 a litre, besi...

Asahi Songwon’s share price climbed to a high of Rs 346.45 as against Rs 332.70 at previous close on the BSE. The stock succumbed to profit...

UltraTech Cement, HFCL, Angel One, Sonata Software, Hathway Cable, Tatva Chintan Pharma Chem and Maharashtra Scooters are among the compani...

Due to the recent price correction, the risk-reward ratio of Cipla has turned favourable. Despite the tough environment, the company is tak...

The stock of drug firm Divi's Labs has corrected 12% since the company announced its March quarter at the beginning of this week.

Lupin Limited says it will challenge a US court order that prevents it from selling a low-cost generic version of Pfizer's nerve pain drug ...

Lupin’s subsidiary Lupin Pharmaceuticals Inc has received tentative ANDA approval for its Pregabalin capsules from the USFDA.

A legal battle between Pfizer and Sun Pharmaceutical has escalated.